Marimed (MRMD) Cash from Investing Activities Growth (3y) (2015 - 2026)
Marimed (MRMD) Cash from Investing Activities Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -53.63% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -55.36% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 34.35% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 33.61% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 15.92% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | -2.45% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | -36.76% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Marimed | 30.77 Mn | 22.33 Mn | 16.23 Mn | 57.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 57.27% |
| Mar 31, 2026 | 52.27% |
| Dec 31, 2025 | 57.20% |
| Sep 30, 2025 | 41.92% |
| Jun 30, 2025 | 67.89% |
| Mar 31, 2025 | 70.27% |
| Dec 31, 2024 | 28.03% |
| Sep 30, 2024 | 24.37% |
| Jun 30, 2024 | -19.32% |
| Mar 31, 2024 | -14.03% |
| Dec 31, 2023 | -128.05% |
| Sep 30, 2023 | -65.99% |
| Jun 30, 2023 | -74.86% |
| Mar 31, 2023 | -72.30% |
| Dec 31, 2022 | 8.26% |
| Sep 30, 2022 | 12.01% |
| Jun 30, 2022 | -70.15% |
| Mar 31, 2022 | -29.11% |
| Dec 31, 2021 | 49.96% |
| Sep 30, 2021 | 17.17% |